\
&
Contact us
\
&
Contact us
Published on | 11 months ago
Programmes HealthThe European Partnership on Rare Diseases (ERDERA) has opened its first Joint Transnational Call for Proposals on 'Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation'. The timeline of the call is as follows:
Research Foundation Flanders (FWO) participates in this call. More information on available funding for researchers based in Flanders and on who can apply & how is specified in the call documents. Questions? Please contact europe@fwo.be .
Projects should address at least two of the following:
Please note, certain approaches, including ATMP therapies and clinical trials, are excluded from this call. Detailed eligibility criteria are outlined in the Call Guidelines.
More information is available on the ERDERA website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
GenderSAFE, funded by Horizon Europe under call topic HORIZON-WIDERA-2023-ERA-01-09, is a project that advances efforts to implement a zero-tolerance approach to gender-based violence in higher education and research in the European Research Area. This overall objective will be achieved through a five-fold strategy. The project exists of a European-wide consortium of six partners. Read more about the GenderSAFE’s five-fold strategy, the role of the Belgian partner Yellow Window and the latest outputs of the project in this testimonial.
